Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a multi-center, double-dummy, double-blind, randomized, active-controlled, parallel
group phase 3 clinical trial to evaluate the efficacy and safety of KALOMIN™ Tab. in patients
with acute bronchitis.
The aim of this clinical trial is to demonstrate that KALOMIN™ Tab. is clinically
non-inferior to Umckamin syrup, as assessed by BSS(Bronchitis Severity Score), in the
treatment of acute bronchitis after 7 days.